Abstract
We have come a long way since the first reports of the existence of aberrant DNA methylation in human cancer. Hypermethylation of CpG islands located in the promoter regions of tumor suppressor genes is now firmly established as an important mechanism for gene inactivation. CpG island hypermethylation has been described in almost every tumor type. Many cellular pathways are inactivated by this type of epigenetic lesion: DNA repair (hMLH1, MGMT), cell cycle (p16INK4a, p15INK4b, p14ARF), apoptosis (DAPK), cell adherence (CDH1, CDH13), detoxification (GSTP1), etc … However, we still know little of the mechanisms of aberrant methylation and why certain genes are selected over others. Hypermethylation is not an isolated layer of epigenetic control, but is linked to the other pieces of the puzzle such as methyl-binding proteins, DNA methyltransferases and histone deacetylase, but our understanding of the degree of specificity of these epigenetic layers in the silencing of specific tumor suppressor genes remains incomplete. The explosion of user-friendly technologies has given rise to a rapidly increasing list of hypermethylated genes. Careful functional and genetic studies are necessary to determine which hypermethylation events are truly relevant for human tumorigenesis. The development of CpG island hypermethylation profiles for every form of human tumors has yielded valuable pilot clinical data in monitoring and treating cancer patients based in our knowledge of DNA methylation. Basic and translational will both be needed in the near future to fully understand the mechanisms, roles and uses of CpG island hypermethylation in human cancer. The expectations are high.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahrendt SA, Chow JT, Xu L, Yang SC, Eisenberg CF, Wu L, Esteller M, Herman JG, Wu L, Decker PA, Jen J, Sidransky D . 1999 J. Natl. Cancer Inst. 91: 332–339
Baylin SB, Hoppener JW, de Bustros A, Steenbergh PH, Lips CJ, Nelkin BD . 1986 Cancer Res. 46: 2917–2922
Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG . 2001 Hum. Mol. Genet. 10: 687–692
Bianco T, Hussey D, Dobrovic A . 1999 Hum. Mutat. 14: 289–293
Bird AP . 1986 Nature 321: 209–213
Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D . 1997 Cancer Res. 57: 4997–5000
Cairns P, Evron E, Okami K, Halachmi N, Esteller M, Herman JG, Bose S, Wang SI, Parsons R, Sidransky D . 1998 Oncogene 16: 3215–3217
Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D . 2001 Clin. Cancer Res. 7: 2727–2730
Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB . 1999 Nat. Genet. 21: 103–107
Catteau A, Harris WH, Xu CF, Solomon E . 1999 Oncogene 18: 1957–1965
Cheah MS, Wallace CD, Hoffman RM . 1984 J. Natl. Cancer Inst. 73: 1057–1065
Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R . 1998 Nature 395: 89–93
Clark SJ, Harrison J, Paul CL, Frommer M . 1994 Nucleic Acids Res. 22: 2990–2997
Collins N, Wooster R, Stratton MR . 1997 Br. J. Cancer 76: 1150–1156
Corn PG, Kuerbitz SJ, Van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG . 1999 Cancer Res. 59: 3352–3356
Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C . 2000 Nat. Genet. 24: 132–138
Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP . 2000 Nat. Genet. 25: 315–319
de Bustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, Baylin SB . 1988 Proc. Natl. Acad. Sci. USA 85: 5693–5697
Dobrovic A, Simpfendorfer D . 1997 Cancer Res. 57: 3347–3350
Du Y, Carling T, Fang W, Piao Z, Sheu JC, Huang S . 2001 Cancer Res. 61: 8094–8099
Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW . 2000 Nucleic Acids Res. 28: E32
Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, Laird PW . 2001 Cancer Res. 61: 3410–3418
Ehrlich M . 2000 DNA alterations in cancer: genetic and epigenetic changes M Ehrlich (ed) Eaton Publishing: Natick pp. 273–291
Esteller M, Levine R, Hedrick Ellenson L, Baylin SB, Herman JG . 1998a Oncogene 17: 2413–2417
Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG . 1998b Cancer Res. 58: 4515–4518
Esteller M, Lluis Catasus, Matias-Guiu X, Mutter G, Baylin SB, Prat J, Herman JG . 1999a Am. J. Pathol. 155: 1767–1772
Esteller M, Sanchez-Cespedes M, Rosell R, Baylin SB, Sidransky D, Herman JG . 1999b Cancer Res. 59: 67–70
Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG . 1999c Cancer Res. 59: 793–797
Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Bussaglia E, Lerma E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG . 2000a J. Natl. Cancer Inst. 92: 564–569
Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG . 2000b Cancer Res. 60: 129–133
Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gozalez S, Tarafa G, Sidransky D, Meltzer SJ . 2000c Cancer Res. 60: 4366–4371
Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG . 2000d New Eng. J. Med. 343: 1350–1354
Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG . 2000e Cancer Res. 60: 2368–2371
Esteller M, Avyzinete E, Corn P, Lothe R, Baylin SB, Aaltonen L, Herman JG . 2000f Oncogene 19: 164–168
Esteller M, Corn PG, Baylin SB, Herman JG . 2001a Cancer Res. 61: 3225–3229
Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedelfank I, Godwin AK, Trojan J, Vaurs-Barrière C, Bignon Y-J, Ramus S, Benitez J, Akiyama Y, Caldes T, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB, Herman JG . 2001b Human Mol. Genetics 10: 3001–3007
Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA, Baylin SB, Herman JG . 2001c Cancer Res. 61: 4689–4692
Esteller M, Cordon-Cardo C, Corn PG, Meltzer SJ, Pohar KS, Watkins DN, Capella G, Peinado MA, Matias-Guiu X, Prat J, Baylin SB, Herman JG . 2001d Cancer Res. 61: 2816–2821
Esteller M, Gonzalez S, Risques RA, Marcuello E, Mangues R, Germa JR, Herman JG, Capella G, Peinado MA . 2001e J. Clin. Oncol. 19: 299–304
Esteller M, Gaidano G, Goodman SN, Zagonel V, Capello D, Botto B, Rossi D, Gloghini A, Vitolo U, Carbone A, Baylin SB, Herman JG . 2002 J. Natl. Cancer Inst. 94: 26–32
Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S . 2001 Lancet 357: 1335–1336
Feinberg AP, Vogelstein B . 1983 Nature 301: 89–92
Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ . 1999 Cancer Res. 59: 1090–1095
Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Nishizuka S, James SP, Wilson KT, Herman JG, Meltzer SJ . 2001 Oncogene 20: 329–335
Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T . 2000 Nat. Genet. 24: 88–91
Goessl C, Krause H, Muller M, Heicappell R, Schrader M, Sachsinger J, Miller K . 2000 Cancer Res. 60: 5941–5945
Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA . 1995 Cancer Res. 55: 4531–4535
Gonzalgo ML, Jones PA . 1997 Nucleic Acids Res. 25: 2529–2531
Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD . 2001 Cancer Res. 61: 900–902
Graff JR, Herman JG, Myohanen S, Baylin SB, Vertino PM . 1997 J. Biol. Chem. 272: 22322–22329
Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B . 1989 Hum. Genet. 83: 155–158
Grunau C, Clark SJ, Rosenthal A . 2001 Nucleic Acids Res. 29: E65–E65
Hedelfank I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J . 2001 New Eng. J. Med. 343: 539–548
Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB . 1995 Cancer Res. 55: 4525–4530
Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB . 1998 Proc. Natl. Acad. Sci. USA 95: 6870–6875
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM . 1994 Proc. Natl. Acad. Sci. USA 91: 9700–9704
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB . 1996a Proc. Natl. Acad. Sci. USA 93: 9821–9826
Herman JG, Jen J, Merlo A, Baylin SB . 1996b Cancer Res. 56: 722–727
Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N . 1998 Cancer Res. 58: 5310–5314
Jones PA . 1999 Trends Genet. 15: 34–37
Jones PA, Laird PW . 1999 Nat. Genet. 21: 163–167
Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP . 1998 Nat. Genet. 19: 187–191
Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R . 1997 Cancer Res. 57: 808–811
Katzenellenbogen RA, Baylin SB, Herman JG . 1999 Blood 93: 4347–4353
Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, Demeester TR, Eads C, Laird PW, Ilson DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV, Meltzer SJ . 2000 J. Natl. Cancer Inst. 92: 1805–1811
Keshet I, Lieman-Hurwitz J, Cedar H . 1986 Cell 44: 535–543
Kikuchi T, Itoh F, Toyota M, Suzuki H, Yamamoto H, Fujita M, Hosokawa M, Imai K . 2002 Int. J. Cancer 97: 272–277
Kusaba H, Nakayama M, Harada T, Nomoto M, Kohno K, Kuwano M, Wada M . 1999 Eur. J. Biochem. 262: 924–932
Lapidus RG, Ferguson AT, Ottaviano YL, Parl FF, Smith HS, Weitzman SA, Baylin SB, Issa JP, Davidson NE . 1996 Clin. Cancer Res. 2: 805–810
Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG . 1994 Proc. Natl. Acad. Sci. USA 91: 11733–11737
Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A . 1992 Cell 69: 905–914
Li Q, Ahuja N, Burger PC, Issa JP . 1999 Oncogene 18: 3284–3289
Liang G, Robertson KD, Talmadge C, Sumegi J, Jones PA . 2000 Cancer Res. 60: 4907–4912
Magdinier F, Wolffe AP . 2001 Proc. Natl. Acad. Sci. USA 98: 4990–4995
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D . 1995 Nat. Med. 1: 686–692
Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H . 2001 Blood 97: 1172–1179
Mohandas T, Sparkes RS, Shapiro LJ . 1981 Science 211: 393–396
Myohanen SK, Baylin SB, Herman JG . 1998 Cancer Res. 58: 591–593
Nakamura M, Watanabe T, Yonekawa Y, Kleihues P, Ohgaki H . 2001 Carcinogenesis 22: 1715–1719
Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A . 1998 Nature 393: 386–389
Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M, Zhou JH, Benedict WF, Jones PA . 2001a J. Natl. Cancer Inst. 93: 1465–1472
Nguyen CT, Gonzales FA, Jones PA . 2001b Nucleic Acids Res. 29: 4598–4606
Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG . 1999 Proc. Natl. Acad. Sci. USA 96: 12754–12759
Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE . 1994 Cancer Res. 54: 2552–2555
Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA . 2000 Res. 60: 5954–5958
Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA . 2001 Hum. Mol. Genet. 10: 903–910
Park TJ, Han SU, Cho YK, Paik WK, Kim YB, Lim IK . 2001 Cancer 92: 2760–2768
Pegg AE, Dolan ME, Moschel RC . 1995 Prog. Nucl. Acid Res. Mol. Biol. 51: 167–223
Plumb JA, Strathdee G, Sludden J, Kaye SB, Brown R . 2000 Cancer Res. 60: 6039–6044
Rainier S, Feinberg AP . 1994 J. Natl. Cancer Inst. 86: 753–759
Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB, Schuebel KE . 2000 Nature 404: 1003–1007
Rice JC, Futscher BW . 2000 Nucleic Acids Res. 28: 3233–3239
Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA . 1999 Nucleic Acids Res. 27: 2291–2298
Robertson KD, Jones PA . 1999 Mol. Cell. Biol. 18: 6457–6473
Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP . 2000 Nat. Genet. 25: 338–342
Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D . 2001 Cancer Res. 61: 939–942
Sanchez-Cespedes M, Esteller M, Hibi K, Cope FO, Westra WH, Piantadosi S, Herman JG, Jen J, Sidransky D . 1999 Clin. Cancer Res. 5: 2450–2454
Schwartsmann G, Fernandes MS, Schaan MD, Moschen M, Gerhardt LM, Di Leone L, Loitzembauer B, Kalakun L . 1997 Leukemia 11: Suppl 1 S28–S31
Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Optiz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW . 2001 Nature 409: 207–211
Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ . 2002 Oncogene 21: 1048–1061
Stimson KM, Vertino PM . 2002 J. Biol. Chem. 277: 4951–4958
Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ . 1997 Cancer Res. 57: 2229–2237
Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K . 2000 Electrophoresis 21: 904–908
Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L . 2000 J. Natl. Cancer Inst. 92: 1511–1516
Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J, Drabkin H, Lerman MI, Gazdar AF, Minna JD . 2001 Proc. Natl. Acad. Sci. USA 98: 13954–13959
Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF . 2001 Cancer Res. 61: 4556–4560
Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP . 2000 Cancer Res. 60: 4044–4048
Virmani AK, Rath A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF . 2000 J. Natl. Cancer Inst. 92: 1303–1307
Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB . 1995 Nat. Med. 1: 570–577
Widschwendter M, Berger J, Hermann M, Muller HM, Amberger A, Zeschnigk M, Widschwendter A, Abendstein B, Zeimet AG, Daxenbichler G, Marth C . 2000 J. Natl. Cancer Inst. 92: 826–832
Wijermans PW, Krulder JW, Huijgens PC, Neve P . 1997 Leukemia 11: 1–5
Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA . 2001 Cancer Res. 61: 8113–8117
Xiong Z, Laird PW . 1997 Nucleic Acids Res. 25: 2532–2534
Xu XL, Wu LC, Du F, Davis A, Peyton M, Tomizawa Y, Maitra A, Tomlinson G, Gazdar AF, Weissman BE, Bowcock AM, Baer R, Minna JD . 2001 Cancer Res. 61: 7943–7949
Xu GL, Bestor TH, Bourc'his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E . 1999 Nature 402: 187–191
Yeager TR, DeVries S, Jarrard DF, Kao C, Nakada SY, Moon TD, Bruskewitz R, Stadler WM, Meisner LF, Gilchrist KW, Newton MA, Waldman FM, Reznikoff CA . 1998 Genes Dev. 15: 163–174
Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG . 2001 Nat. Genet. 28: 29–35
Yuan Y, Mendez R, Sahin A, Dai JL . 2001 Cancer Res. 61: 5558–5561
Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA . 2001 Oncogene 20: 7787–7796
Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD . 2001a Cancer Res. 61: 249–255
Zochbauer-Muller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD . 2001b Cancer Res. 61: 3581–3585
Acknowledgements
The work of my laboratory is sponsored by the Health Department of the Spanish Government, the I+D+I SAF 2001-0059 Grant and the International Rett Syndrome Association. I would like to thank Dr Esteban Ballestar and Dr Mario F Fraga for their critical reading of the manuscript. I apologize to all authors whose work on DNA methylation or whose favorite hypermethylated gene has not been mentioned due to space limitations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Esteller, M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21, 5427–5440 (2002). https://doi.org/10.1038/sj.onc.1205600
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205600
Keywords
This article is cited by
-
Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability
Experimental & Molecular Medicine (2024)
-
Molecular complexity of diffuse large B-cell lymphoma: a molecular perspective and therapeutic implications
Journal of Applied Genetics (2024)
-
Correlation of DNA methylation of DNMT3A and TET2 with oral squamous cell carcinoma
Discover Oncology (2024)
-
Low levels of circulating methylated IRX3 are related to worse outcome after transcatheter aortic valve implantation in patients with severe aortic stenosis
Clinical Epigenetics (2023)
-
Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer
BMC Cancer (2023)